Alnylam Pharmaceuticals reported $24.33B in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.28B 1.63B
Agios Pharmaceuticals AGIO:US $ 1.22B 0.38B
Alnylam Pharmaceuticals ALNY:US $ 17.65B 2.06B
Amgen AMGN:US $ 129.97B 0.89B
Arrowhead Research ARWR:US $ 3.72B 1.14B
Avrobio Inc AVRO:US $ 0.04B 0.02B
Biocryst Pharmaceuticals BCRX:US $ 1.97B 1.04B
Biomarin Pharmaceutical BMRN:US $ 15.33B 1.08B
Bluebird Bio BLUE:US $ 0.3B 0.05B
Intercept Pharmaceuticals ICPT:US $ 0.41B 0.07B
IONIS PHARMACEUT IONS:US $ 5.25B 0B
Mirati Therapeutics MRTX:US $ 3.73B 0.84B
Moderna Inc MRNA:US $ 56.82B 12.6B
Neurocrine Biosciences NBIX:US $ 9.32B 0.36B
Novartis NVS:US 203.52B 10.87B
Ptc Therapeutics PTCT:US $ 2.86B 0.2B
Regeneron Pharmaceuticals REGN:US $ 64.93B 10.87B
Regulus Therapeutics RGLS:US $ 0.03B 0.01B
Sangamo Biosciences SGMO:US $ 0.61B 0.24B
Sanofi SNY:US 127.77B 1.58B
Sarepta Therapeutics SRPT:US $ 6.56B 0.25B
Takeda 4502:JP 6041.08B 506.36B
Ultragenyx Pharmaceutical RARE:US $ 4.17B 0.87B
Vertex Pharmaceuticals VRTX:US $ 72.14B 5.45B
Xencor XNCR:US $ 1.63B 0.05B
YTE INCY:US $ 16.83B 0.75B